Instructions for Umckalor
Description Umckalor:
Transparent or slightly opalescent liquid from light brown to reddish brown.
Oral solution. 20 ml and 50 ml each in a hydrolytic class III amber glass vial equipped with an LDPE dropper and a polypropylene screw cap. Each bottle is placed in a cardboard box.
pharmachologic effect Umckalor
Pharmacological action - antimicrobial.
Pharmacodynamics Umckalor:
Has antimicrobial effect. It has mucolytic properties, promotes an increase in nonspecific resistance of the organism.
Pharmacokinetics Umckalor:
Pelargonium sidoid root extract liquid contains a large amount of biologically active substances, which together determine its pharmacological activity. Data on the pharmacokinetics of individual chemical components that make up the extract are insufficient for extrapolation to the drug as a whole.
Indications for use Umckalor:
Acute and chronic infectious and inflammatory diseases of the respiratory tract and ENT organs (sinusitis, rhinopharyngitis, tonsillitis, bronchitis) as part of complex therapy.
Contraindications Umckalor:
Hypersensitivity to drug components;
Bleeding tendency;
Severe hepatic and renal impairment;
Simultaneous use of anticoagulants;
Children under 1 year of age (due to the presence of ethyl alcohol in the preparation).
Carefully. Alcoholism, TBI, brain diseases, impaired liver and kidney function (no experience with use), children from 1 year old.
Application during pregnancy and lactation
Due to the lack of sufficient clinical data, the use of the drug during pregnancy and breastfeeding is not recommended.
Side effects Umckalor:
The assessment of the frequency of adverse reactions is based on the WHO classification: very often - 1/10 of appointments (≥10%); often - 1/100 appointments (≥1, but <10%); infrequently - 1/1000 appointments (≥0.1, but.
From the immune system, skin and subcutaneous tissue. Rarely - the occurrence of allergic reactions.
Respiratory, thoracic and mediastinal diseases. Rarely - minor nosebleeds.
Gastrointestinal disorders. Uncommon - complaints from the gastrointestinal tract (such as nausea, vomiting, epigastric pain or diarrhea), rarely - slight bleeding of the gums. Umckalor
.Signs of liver dysfunction (such as yellowing of the skin, yellowing of the whites of the eyes) may appear. The causal relationship of this manifestation with the use of drugs has not been confirmed, the frequency of occurrence is unknown.
Interaction
With simultaneous use with anticoagulants, including coumarin derivatives, it is possible to increase their anticoagulant action and develop bleeding (nosebleeds, bleeding gums).
Method of administration and dosage Umckalor:
Inside, 30 minutes before meals, with a small amount of liquid. When dispensing the drug, the bottle should be held vertically, if necessary, gently tapping on the bottom of the bottle.
Adults and children over 12 years old - 20-30 drops, 3 times a day; 6-12 years old - 10-20 drops 3 times a day; from 1 year to 6 years - 5-10 drops 3 times a day.
After the symptoms of the disease disappear, it is recommended to continue treatment for several days to prevent relapse. The average duration of the course of treatment is 10 days.
Overdose Umckalor:
Overdose cases have not been reported to date.
The drug is well tolerated.
pecial instructions Umckalor
During storage, liquid plant extracts tend to become cloudy, but this does not affect their pharmacological effectiveness. Since Umckalor is a natural product, slight changes in color and taste of the preparation are possible.
Due to the ethanol content of 12% (v / v) in the preparation, it should be borne in mind that the maximum single dose for children over 12 years old and adults contains 0.125 g of absolute ethyl alcohol, the maximum daily dose for children over 12 years old and adults contains 0.375 g absolute ethyl alcohol. A single dose for children under 12 years of age contains less than 0.1 g of absolute ethyl alcohol.
In the absence of a therapeutic effect against the background of taking the drug for 7 days, maintaining an elevated temperature for several days, the appearance of shortness of breath or bloody sputum, signs of liver dysfunction (such as yellowing of the skin, yellowing of the whites of the eyes), you should consult your doctor.
Influence on the ability to drive and operate machinery. When using the drug, care should be taken when engaging in potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms). Umckalor
